Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-003843
Accepted
2024-12-20 00:15:10
Documents
1
Effectiveness Date
2024-12-19
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 597
  Complete submission text file 9999999995-24-003843.txt   1839
Mailing Address 5858 HORTON STREET, SUITE 370 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET, SUITE 370 EMERYVILLE CA 94608 (510) 318-9098
Estrella Immunopharma, Inc. (Filer) CIK: 0001844417 (see all company filings)

EIN.: 861314502 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-283770 | Film No.: 241564896
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)